Introduction. Angiotensin II (AngII) regulates blood pressure and water and electrolyte metabolism through the stimulation of NAD(P)H oxidase and production of reactive oxygen species (ROS) such as O 2 -, which is metabolised by superoxide dismutase, catalase and glutathione peroxidase. We assessed the role of AT 1 and AT 2 receptors, NAD(P)H oxidase and protein kinase C (PKC) in Ang II-induced sodium and water excretion and their capacity to stimulate antioxidant enzymes in the rat hypothalamus, a brain structure known to express a high density of AngII receptors. Materials and methods. Male Sprague-Dawley rats were intracerebroventricularly (ICV) injected with AngII and urinary sodium and water excretion was assessed. Urine sodium concentration was determined using flame photometry. After decapitation the hypothalamus was microdissected under stereomicroscopic control. Superoxide dismutase, catalase and glutathione peroxidase activity were determined spectrophotometrically and extracellular signal-regulated kinase (ERK1/2) activation was analysed by Western blot. Results. AngII-ICV resulted in antidiuresis and natriuresis. ICV administration of losartan, PD123319, apocynin and chelerythrine blunted natriuresis. In hypothalamus, AngII increased catalase, superoxide dismutase and glutation peroxidase activity and ERK1/2 phosphorylation. These actions were prevented by losartan, apocynin and chelerythrine, and increased by PD123319. Conclusions. AT 1 and AT 2 receptors, NAD(P)H oxidase and PKC pathway are involved in the regulation of hydromineral metabolism and antioxidant enzyme activity induced by AngII.
Introduction
The brain renin-angiotensin system (RAS) has an important role in the regulation of sympathetic nervous activity, arterial blood pressure and water and electrolyte balance. Intracerebroventricular (ICV) administration of angiotensin II (Ang II) increases blood pressure, sympathetic outflow, water intake, sodium excretion and vasopressin release, and decreases plasma sodium (Na + ) and urine volume. These central actions of Ang II are mediated by angiotensin II type 1 receptors which have been found in high density in cardiovascular and hydromineral regulatory brain areas. 1 Among them the hypothalamus constitutes a complex structure involved in the modulation of autonomic, neuroendocrine, and behavioural arousal caused by threatening stimuli, and known to express AT 1 and AT 2 receptors, with quite different functional roles. The majority of evidence point to the AT 1 receptor as key for hypertensive responses such as an increase in water drinking, sodium appetite, sympathetic vasoconstriction, and vasopressin secretion and the behavioural responses to Ang II. For example, Ang II-induced water intake was blocked by an AT 1 receptor antagonist but persisted when animals were pretreated with an AT 2 receptor antagonist. 2 Furthermore, antisense oligonucleotides designed to block AT 1 receptor expression attenuated angiotensin II-induced water intake in a dose-dependent manner. 3 Accumulated evidence indicates that NAD(P)H oxidase is a key source of Ang II-stimulated O 2 production in the brain, similar to its role in the Ang II-induced O 2 generation in vascular tissues. 4, 5 The major enzymatic sources of O 2 generation in the brain include NAD(P)H oxidase, xanthine oxidase, mitochondrial respiration and uncoupled nitric oxide synthase (NOS). 6, 7, 8 After assembly of the subunits, NAD(P)H oxidase is activated to catalyse the reduction of the molecular oxygen to superoxide which is converted to H 2 O 2 by the superoxide dismutase (SOD) family of enzymes. H 2 O 2 is, in turn, converted to water by catalase or glutathione peroxidase. 9, 10 AT 1 receptor and NAD(P)H oxidase mediate angiotensin II-stimulated antioxidant enzymes and mitogen-activated protein kinase activity in the rat hypothalamus
There are a wide variety of AT 1 receptor signalling pathways in neurons. 11, 12 Thus, it has been suggested that the molecular mechanisms underlying Ang II central actions could be related to the NAD(P)H cascade. However, nothing is known, about a potential antagonistic role of the AT 2 receptor in this process in the brain. In fact, it has been shown that administration of NAD(P)H inhibitors, diphenyleneiodonium chloride (DPI) and apocynin, into the rostral ventrolateral medulla (RVLM) or brain ventricles attenuates the pressor response to Ang II in rats; 13, 14 and microinjection of DPI or antisense oligonucleotides to the p22phox or p47phox subunits of NAD(P)H oxidase into the RVLM partly prevents the Ang II-induced increase in local O 2 production. 13 Furthermore, extracellular application of a selective NAD(P)H oxidase inhibitor, gp91 dstat, decreased by half the Ang II-induced increase in neuronal firing in primary cultures from the hypothalamus and brainstem, 15 and adenoviralmediated expression of a dominant-negative isoform of Rac1, a critical component for NAD(P)H oxidase activation and O 2 production, inhibited the Ang II-induced influx of extracellular Ca 2+ in neurons. 16 However, there is no evidence for a direct involvement of the AT 1 receptor and NAD(P)H oxidase in the activation of the antioxidant enzymes in the hypothalamus.
It is well established that reactive oxygen species (ROS) can influence multiple intracellular events by activating receptor and non-receptor tyrosine kinases, inhibiting protein tyrosine phosphatases, and regulating redox-sensitive transcription factors and intracellular Ca 2+ homeostasis. 17, 18 In particular, ROS-induced cellular events have been implicated, in part, in the activation of mitogenactivated protein kinases (MAPK), including the extracellular signal-regulated kinases (ERK 1/2), c-Jun NH 2 -terminal kinases (JNK), and p38 MAPK. 5, 18, 19 Studies have shown that microinjection of Ang II into the RVLM resulted in AT 1 receptor-dependent phosphorylation (activation) of p38 MAPK and p42/44 MAPK via a redoxsensitive, NAD(P)H oxidase-dependent mechanism. 13 Conversely, inhibition of MAPKs abolished the stimulatory effect of Ang II on noradrenaline reuptake in neuronal cultures from the hypothalamus and brainstem, 20 and markedly attenuated the pressor effect of Ang II in the RVLM of rats. 13 This evidence suggests the functional importance of MAPKs in the regulation of cardiovascular responses and a role for central Ang II and O 2 -induced MAPK activation.
Since superoxide-generating and -scavenging systems throughout the brain, 21 and ROS signalling, are related to a wide range of Ang II-regulated cellular processes, we examined the involvement of AT 1 and AT 2 receptors, NAD(P)H oxidase and protein kinase C (PKC) in the natriuretic and antidiuretic responses elicited by central administration of Ang II in conscious hydrated rats. In addition, we assessed the Ang II-stimulated antioxidant enzyme activity of catalase, superoxide dismutase and glutathione peroxidase, as well as the activation of ERK1/2 in the rat hypothalamus.
Materials and methods
Experiments were performed on adult male Sprague-Dawley rats (220-280 g, body weight) from the 'Rafael Rangel' National Institute of Health, Caracas, housed in controlled conditions and provided with standard rat chow ad libitum. The procedures used in these experiments were reviewed and approved by the Animal Care and Use Committee of the Central University of Venezuela, School of Pharmacy, Caracas, Venezuela.
Functional experiments
Under pentobarbital anaesthesia (40 mg/kg, intraperitoneal), a cannula was implanted in the left lateral cerebral ventricle (1 mm caudal to the coronal suture and 1.5 mm lateral to the midsagital suture) in Sprague-Dawley rats (220-280 g) by using a stereotaxic instrument. The cannula (20GA hypodermic needle, 4.0-4.2 mm length and sealed with adhesive silicon) was secured to the skull with acrylic cement. A minimum of 3 days was allowed for recovery. Each animal was manually handled and ICV-injected with the correspondent compound with a Hamilton syringe fitted with a stop to prevent needle penetration past the cannula tip. The animals were randomly distributed into the following pretreatments: 1. VEH: receiving ICV injection of saline (5 or 10 µl); 2. LOS: administration of losartan (100 mg/5 ml, ICV); 3. PD: administration of PD123319 (10 nmol/5 µl, ICV), 4. APO: administration of apocynin (4 µg/5µl ICV); 5. CHE: administration of chelerythrine (50 mM/5 ml, ICV). Pretreatment was performed 15 minutes before ICV-Ang II or saline. At 09:00, half of the rats receiving each pretreatment were injected ICV, as a bolus in 10 sec, with saline solution (5 ml) or with Ang II in saline solution (50 pmol/5 ml; American Peptides Company Inc., Sunnyvale, CA, USA), followed by 20 ml/kg water orally. Animals were weighed and placed in metabolic cages. The bladder was emptied at the beginning and the end of the experiment by gentle suprapubic massage and verification was done visually. Food and water were not available during the experiment. Urine was collected at 1 h and ventricular cannula placement was confirmed postmortem by examining the distribution of an ICV injection of 5 ml of fast green dye, given before animal sacrifice. Data were used only if the dye was distributed in the lateral, third, and fourth ventricles. Each urine sample was analysed for sodium concentration using a flame photometer. Results were expressed as mEq/100 g body weight.
In vitro experiments
Rats were killed by decapitation; microdissection of the hypothalamus was completed under stereomicroscopic control and the tissue was kept in ice-cold Krebs-Ringer Buffer (KRB) until assay. Tissue samples were incubated for 30 minutes with the agonist and preincubated for 10 minutes with the correspondent antagonist or inhibitor.
Determination of catalase enzymatic activity
Catalase (CAT) activity was determined at 25°C according to Aebi. 22 Catalase activity was measured as the rate of enzymatic decomposition of H 2 O 2 monitored as a decrease of absorbance at 240 nm. The reaction mixture contained 10 mM H 2 O 2 in a 10 mM phosphate buffer pH 7.0, and 25 ml of proteins obtained from hypothalamus homogenate, for a final volume of 750 mL. Results were expressed as k/mg protein.
Superoxide dismutase activity determination SOD activity was determined spectrophotometrically using a modification of the method of Oberley and Spitz, 23 based on the ability of the SOD present in the homogenate to inhibit the reduction of nitrotetrazolium blue (NTB) by O 2 generated by the addition of xanthine-xanthine oxidase system present in the incubation mixture. Results were expressed as U/mg protein. One unit of SOD activity is defined as the amount of enzyme required to inhibit by 50% the rate of crystal formation generated by the xanthine-xanthine oxidase system.
Glutathione peroxidase (GPx) activity determination
Glutathione peroxidase (GPx) activity was measured according to the method of Flohé, 24 using a reaction coupled to glutathione reductase. Reduced glutathione is used by GPx to reduce H 2 O 2 , which in turn is regenerated by the glutathione reductase from reduced glutathione and NAD(P)H. Results were expressed as enzyme activity in U/mg protein (ε = 6.22 mM −1 cm −1 ). One unit of GPx represents 1 mmol NAD(P)H oxidised/min per mg protein.
Protein determination
Protein was determined according to the method of Lowry et al. 25 using bovine serum albumin as standard.
Western immunoblot analysis
Hypothalamic tissue was incubated at 37ºC with Ang II (10 -7 M), in the presence or absence of the correspondent antagonists. After incubation tissue was homogenised in lysis buffer containing 50 mM Trisma base, 5 mM EDTA, 1 mM NaF, 1 mM Na 3 VO 4 , protease inhibitors mixture and 1% Triton X-100, pH 7.4. For Western blot analysis, samples of rat hypothalamus (50 µg protein/ sample) were separated by 10% SDS-polyacrylamide gel electrophoresis under denaturising and reducing conditions and transferred to nitrocellulose membranes. The membranes were incubated for 1 hour in blocking buffer (TBS-Tween 0.1% + 10% non-fat dried milk) at room temperature. Next, the membranes were incubated overnight at 4°C with rabbit anti-phospho-ERK or anti-ERK 1/2 (Cell Signaling Technology) (1:1000). Then, the membranes were incubated with anti-rabbit IgG conjugated to horseradish peroxidase (Cell Signaling Technology) (1:10.000), for 1 hour at room temperature. After each incubation, the membranes were washed six times thoroughly with TBS-Tween 1X. Protein signals were detected by a chemiluminescent detection system (Super-Signal® West Pico Chemiluminescent Substrate) and densitometry analysis was performed using Quantity One 1-D ®-BioRad software.
Statistical analysis
The results are expressed as the means ± SEM. Statistical significance was assessed by two-way ANOVA and the Newman-Keul's test for in vivo experiments, one-way ANOVA and the Bonferroni test for in vitro experiments. p-values < 0.05 were considered statistically significant.
Results

Effect of central administration of losartan, PD 123319, apocynin and chelerythrine on ICV-Ang II-induced urinary sodium and water excretion
The ICV-Ang II action on urinary volume and sodium excretion in hydrated rats treated with losartan, apocynin or chelerythrine is presented in Figure 1 . Two-way ANOVA and the Newman-Keul's test revealed that ICV-Ang II significantly decreased urine volume at 1 hour. The Ang II-induced decrease in urinary volume was associated with enhanced sodium excretion. The AT 1 receptor blocker losartan reduced basal water excretion and inhibited further reduction induced by Ang II. Antidiuretic effect of ICV-Ang II was not altered by the NAD(P)H oxidase inhibitor APO or the PKC inhibitor CHE, while it was increased by the AT 2 receptor blocker PD 123319. LOS reduced basal sodium excretion, while all 
Effect of NAD(P)H oxidase and PKC inhibitors, and AT 1 and AT 2 receptor blockers on Ang II-stimulated CAT, SOD and GPx activities in rat hypothalamus
As shown in Figures 2, 3 and 4, incubation of hypothalamic tissue with Ang II (10 -7 M) significantly increases catalase activity (2.0084 ± 0.12fold compared with control) (Figure 2 ), superoxide dismutase activity (2.358 ± 0.11-fold compared with control) (Figure 3 ) and glutathione peroxidase activity (3.7304 ± 0.2-fold compared with control) (Figure 4) . These effects were inhibited by the addition to the incubation media of losartan (LOS, 10 -6 M), apocynin (APO, 10 -4 M) and chelerythrine (CHE, 6.5 µM), respectively. While Ang II action was potentiated or tended to increase by the addition of PD 123319 
Effect of losartan, PD 123319 and apocynin on Ang II-induced ERK 1/2 activation in the rat hypothalamus
The upper panel of Figure 5 shows the results of immunoblots analysed in hypothalamus and probed with antibodies against p-ERK and ERK. The bar graphs show the results of densitometric analyses from pooled data (N=4) and expressed as p-ERK/ERK ratio. 
Discussion
Despite the importance of RAS in central cardiovascular and volume homeostasis, the precise pathways and signalling mechanisms used by Ang II in the brain are incompletely understood. It is well established that ROS are important intracellular messengers of many physiological and pathological effects of circulating Ang II. 18 In the brain, ROS are best known for their role in the pathogenesis of primary neurodegenerative diseases, such as amyotrophic lateral sclerosis 26 and Alzheimer's disease. 27 Growing evidence indicates that ROS are critically involved in the excitatory actions of brain Ang II. In effect, Ang II increases O 2 production and neuronal firing rate in neuronal cell culture, the subfornical organ (SFO), 15, 28 the rat hypothalamus, brainstem, 14 and in primary neuronal cell culture and in neurons isolated from the dorsomedial nucleus of the solitary tract. 8 These actions are mediated by AT 1 receptors, since they are prevented by losartan. 15, 28 Furthermore, there is evidence implicating superoxide anion as an intracellular signalling molecule in the Ang II-dependent mediation of blood pressure regulation. 14, 28 In fact, changes in mean arterial blood pressure and heart rate elicited by ICV administration of Ang II can be abolished by adenoviral-vector-mediated central overexpression of SOD. 28 It has been suggested that brain Ang II modulation of sodium metabolism could also be mediated through the stimulation of AT 1 receptor/NAD(P)H oxidase and production of O 2 -. Our present results support this possibility, because ICV administration of losartan and apocynin completely attenuated the natriuretic response to Ang II. Furthermore, the inhibitory action of PD123319 suggests the involvement of AT 2 receptor in this action. These results are in line with those reported by Mayorov and Geoffrey 29 who demonstrated that bilateral microinjection of apocynin into the RVLM markedly attenuated the pressor and tachycardic response to air-jet stress in rabbits, without altering haemodynamic parameters at rest.
Although the AT 1 receptor blocker unexpectedly reduced 'per se' basal water excretion, our results confirm the AT 1 receptor mediation of the Ang II-induced antidiuretic action because losartan inhibited further volume reduction. On the other hand, ICV-Ang II-induced urinary volume reduction was enhanced by PD123319 and not altered by apocynin, suggesting that under our experimental conditions vasopressin secretion (antidiuresis) induced by central Ang II is regulated by the AT 2 receptor and is independent of ROS production, despite the fact that it was reported that Ang II applied to the paraventricular nucleus of the hypothalamus is associated to apocyninsensitive production of the superoxide anion. 14 to water and molecular oxygen and GPx, which reduces H 2 O 2 and lipid peroxidases to water and lipid alcohols, respectively, and in turn oxidises glutathione to glutathione disulphide. 10 Thus, it is plausible to suggest that, in the hypothalamus, AT 1 receptor signalling is also associated with NAD(P)H oxidase activation and O 2 production, by the subsequent activation of antioxidant enzymes (CAT, SOD and GPx). 11, 12 Our present in vitro results support this notion, because incubation of hypothalamic tissue with apocynin, a pharmacological inhibitor of NAD(P)H oxidase, or with AT 1 receptor antagonist losartan, completely attenuated Ang II-stimulated CAT, SOD and GPx activity, suggesting the existence of a counter regulatory mechanism which exerts an immediate control on local ROS levels in the hypothalamus. These effects are in line with functional evidence using patch clamping of dissociated NTS neurons anterogradely labelled via the vagus, where it was found that Ang II potentiates L-type Ca 2+ currents, an effect mediated by AT 1 receptors and abolished by the NAD(P)H oxidase assembly inhibitor apocynin and the peptide inhibitor pg91 phox docking sequence. 8 On the other hand, blockade of the AT 2 receptor with PD123319 resulted in a further increase of AT 1mediated stimulation in the activity of the three antioxidant enzymes and ERK 1/2 phosphorylation, suggesting an antagonistic function of both receptor types. Such an antagonism has been reported previously on Ang II-induced endothelial superoxide formation 30 and in the present study in the antidiuretic action of ICV-Ang II.
There is evidence suggesting that in peripheral tissues NAD(P)H oxidase is regulated by PKC, 5, 18, 31 an enzyme which is known to be activated by Ang II in neurons. 12 Studies using neurons cultured from the hypothalamus and brain stem of newborn rats demonstrated that Ang II elicits a positive chronotropic effect, 32, 33 increases total calcium current (I Ca ), decreases the voltagedependent delayed rectifier (I Kv )and A-type (I A ) K + currents, and consequently increases neuronal firing rate via the AT 1 receptor. 32, 34, 35 The specific intracellular signalling pathways involved in these effects mediated by the AT 1 receptor indicate that Ang II-stimulated increases in neuronal firing rate and decreases in I Kv are related to activation of PKC and Ca 2+ -calmodulin dependent kinase. 12 Both kinases have been involved in ROS production in several cell lines including neurons, 9 and inhibition of these kinases is a fundamental requirement for the attenuation of K + currents and neuronal firing rate in neuronal activity. 12 Our present results support the role of PKC in the signalling of the AT 1 receptor and NAD(P)H oxidase as well as antioxidant enzyme stimulation in brain, since preincubation of hypothalamic tissue with the PKC inhibitor, chelerythrine chloride, completely attenuated the Ang II-stimulated activity of the antioxidant enzymes CAT, SOD and GPx in vitro. As many physiological responses elicited by the brain are due to changes in neuronal activity, it is logical that the same mechanisms involved in Ang II modulation of neuronal activity in vitro are involved in Ang II-mediated responses in vivo. In effect, it has been shown that the specific inhibitor of PKC-α, Go-6976, attenuates dipsogenic response to ICV-Ang II 36 and that the PKC inhibitor chelerythrine inhibits the natriuretic and kaliuretic response produced by ICV-Ang II in rats (Israel et al. 37 , current results). These data and our current results indicate that redox signalling, NAD(P)H-oxidasedependent production of superoxide, PKC activation and AT 1 receptors are involved in Ang II-induced stimulatory actions in the hypothalamus, similarly to the Ang II modulation of I Kv and neuronal activity. 15, 35, 38 It has been reported that ERK1/2 are activated by oxidative stress and Ang II in a variety of cell types. 39 Activation of p38 MAPK and ERK1/2 by Ang II has been reported in mesenteric smooth muscle cells, 40,41 the aorta, 42 or cardiomyocytes; 42, 43 and blockade of NAD(P)H oxidase with DPI effectively inhibits Ang II-induced ROS production, ERK phosphorylation and vascular smooth muscle hypertrophy. 44 In regard to the central nervous system, Chan et al. 13 demonstrated that Ang II injection into the RVLM increased phosphorylation of ERK 1/2 and p38 MAPK, but not in JNK. The effects were attenuated by application into RVLM of DPI, antisense oligonucleotides that target p22phox or p47phox mRNA, or the SOD mimetic tempol. Furthermore, phosphorylation of serine residues of p47phox induced by Ang II in the RVLM, was blunted by losartan, and manifested a temporal profile that correlated positively with O 2 production induced by the octapeptide. 13 In extension of previous reports in the brain, our findings identified a role for NAD(P)H oxidase-derived O 2 as a second messenger in the hypothalamus which mediates Ang II-induced activation of p38 MAPK or ERK1/2 via AT 1 receptors. In effect, our results demonstrate that apocynin and losartan not only inhibit the activation of Ang II-stimulated antioxidant enzyme Paper SAGE Publications 2010 Los Angeles, London, New Delhi and Singapore activity, but are also able to blunt Ang II-induced ERK 1/2 activation, suggesting a role for ROS and the AT 1 receptor. It follows that by acting on the AT 1 receptors in the hypothalamus, Ang II initiates a signalling cascade which leads to phosphorylation of p38 MAPK or ERK1/2 mediated by NADPH oxidase-derived O 2 -, possibly after the induction of serine phosphorylation of the p47phox subunit as is was shown in RVLM. 45 In conclusion, our present results demonstrate that, in rat hypothalamus, Ang II increases the activity of the antioxidant enzymes CAT, SOD and GPx, via stimulation of the AT 1 receptor and NAD(P)H-oxidase dependent ROS production and PKC stimulation. In addition the present study unveiled a signalling pathway in which Ang II induces AT 1 
